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Pressure guided hydrationAbstract Background: Contrast induced nephropathy (CIN) is an important complication of
cardiac catheterization. Adequate hydration is the simplest and most effective way of protecting
renal function. This study was designed to determine whether left ventricular end diastolic pressure
(LVEDP). Guided hydration would be superior to routine hydration in patients at risk for CIN
undergoing cardiac catheterization.
Methods: Prospective randomized trial including 200 patients at Alexandria main university
hospital.
Laboratory investigation: Serum urea, creatinine, eGFR by the MDRD equation, Echocardio-
graphic measurement of the left ventricular ﬁlling pressure (LVFP) using the ratio (E/septal e`).
LVEDP measured systematically (in mmHg) using a pigtail catheter. Patients were randomized
in a 1:1 fashion to either LVEDP-guided hydration (group 1) or standard hydration (group 2).
The primary endpoint was 25% or 0.5 mg/dl or more increase in SCr (two values measured on days
1 and 4), the secondary endpoints were major adverse events (death, myocardial infarction and
dialysis) occurring within 30 days.
Results: We found statistically signiﬁcant difference between the two types of hydration regarding
the occurrence of the primary endpoint (p= 0.046). We found no statistically signiﬁcant difference
between the two groups regarding the secondary endpoints. Statistically signiﬁcant correlation was
found between LVEDP prior to contrast administration and that at the end of the procedure
(p< 0.001). Statistically signiﬁcant positive correlation was found between the LVFP and the
LVEDP both prior to contrast administration and at the end of the procedure (p< 0.001).
Conclusions: LVEDP-guided hydration is superior to standard hydration in prevention of CIN.
Hydration can be done based on LVFP in patients with pre-procedure normal LVF and in patients
with pre-procedure elevated LVFP but not in those patients with inconclusive LVFP in which
hydration should be guided by the invasively measured LVEDP.
ª 2014 TheAuthors. Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Cardiology. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Ischemic heart disease is the most common cardiac disease and
is most commonly caused by obstruction of the coronary arter-
ies by atheromatous plaque.1 Coronary angiography (CAG)
remains the standard for identifying the presence or absence
of arterial narrowings related to coronary artery disease and
provides the most reliable anatomic information.2
Contrast induced nephropathy (CIN) is an important com-
plication of coronary interventions and is most commonly
deﬁned as acute renal failure occurring within 48 h of exposure
to intravascular radiographic contrast material that is not
attributable to other causes, CIN has many risk factors which
are preexisting impairment of renal function, diabetes mellitus
(DM), nephrotoxic drugs, reduction of intravascular volume,
advanced age, multiple myeloma and sepsis.3
Adequate hydration is the simplest and most effective way
of protecting renal function. Multiple trials studied the impact
of hydration on prevention of CIN.4
2. Aim of the work
The study was designed to determine whether left ventricular
end diastolic pressure (LVEDP) guided hydration would be
superior to routine hydration in patients at risk for CIN under-
going cardiac catheterization.
3. Patients
200 Patients at Alexandria main university hospital undergo-
ing conventional CAG or percutaneous coronary revasculari-
zation were included in this prospective study.
3.1. Inclusion criteria (high risk patients)
 Estimated GFR< 90 mL/min/1.73 m2 by MDRD
equation.
And at least one of the following:
 DM.
 Age > 75 years.
 Hypertension (HTN) (>140/90 or on antihypertensive
treatment).
 History of heart failure.
3.2. Exclusion criteria
 Pulmonary edema or acute decompensated heart failure.
 Contrast exposure within 48 h.
 Severe valvular heart disease or mechanical aortic valve.
 Heart or kidney transplant status.
 >15% Change in serum creatinine (SCr) in previous
2 days.
 Patients on regular hemodialysis.
4. Methods
An informed consent was obtained from every patient before
the following:1. Thorough history talking with special emphasis on: risk
factors and drug history.
2. Complete clinical examination.
3. Laboratory investigation.
 Serum urea, creatinine.
 GFR estimated by the MDRD equation.GFR= 186 · Serum Creatinine1.154 · Age0.203 ·
1.212 (if Black) · 0.742 (if Female).54. Standard 12 lead ECG and CAG.
5. Transthoracic echocardiography including assessment of
the left ventricular ejection fraction and additional mea-
surement of the left ventricular ﬁlling pressure (LVFP)
using the ratio (E/septal e`) by recording the mitral valve
annular velocities using pulsed wave Doppler and tissue
Doppler imaging in the LVEDP-guided hydration group.
6. LVEDP measured systematically (in mmHg) using a pigtail
catheter (initially prior to contrast administration then
another measurement at the end of the procedure) in the
LVEDP-guided hydration group.
7. A non-ionic, low-osmolar contrast medium used for all
procedures.
8. Hydration was done using intravenous 0.9% saline.
Patients were randomized in a 1:1 fashion to either
LVEDP-guided hydration or standard hydration as follows:
LVEDP (in mmHg)-
guided hydration
Standard hydration
Pre-procedure 3 mL/kg · 1 h 3 mL/kg · 1 h
During procedure LVEDP Rate 1.5 mL/kg/h
<13 5 mL/kg/h
13–18 3 mL/kg/h
>18 1.5 mL/kg/h
Post-procedure Continued · 4 h Continued · 4 hThe primary endpoint was 25% or 0.5 mg/dl or more
increase in SCr (two values measured on days 1 and 4), the sec-
ondary endpoints were major adverse events (death, myocar-
dial infarction and dialysis) occurring within 30 days.5. Results
5.1. Patient demographics
The 100 consecutive patients in the standard hydration group
were 52 males (52%) and 48 females (48%). The age ranged
from 36 to 77 years with a mean age of 57.88 ± 9.13 years
while the other 100 patients in the LVEDP-guided hydration
were 60 males (60%) and 40 females (40%). The age ranged
from 40 to 77 years with a mean age of 57.54 ± 8.34 years.
 Risk factors:
DM: Among the standard hydration group we had 54
patients with DM (54%) and in the LVEDP-guided hydration
group we had 42 patients with DM (42%).
020
40
60
80
100
120
CIN No CIN
16.0
84.0
7.0
93.0
Pe
rc
en
ta
ge
Standard
LVEDP guided
p=0.046*
Fig. 1 Comparison between the two groups of hydration
according to the occurrence of an increase in SCrP 25% of the
baseline.
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patients with HTN (84%) and in the LVEDP-guided hydra-
tion group we had 75 patients with HTN (75%).
Smoking: Among the standard hydration group we had 54
non-smokers (54%), 19 ex-smokers (19%), 27 current smokers
(27%) and in the LVEDP-guided hydration group we had 43
non-smokers (43%), 20 ex-smokers (20%), 37 current smokers
(37%).
Dyslipidemia: Among the standard hydration group we had
35 patients with dyslipidemia (35%) and in the LVEDP-guided
hydration group we had 32 patients (32%) with dyslipidemia
(32%).
5.2. Impact of LVEDP-guided hydration on prevention of CIN
as a primary endpoint
We found statistically signiﬁcant difference between the two
types of hydration regarding the occurrence of the primary
endpoint (p= 0.046) .16 patients (16%) in the standard hydra-
tion group developed an increase in SCrP 25% of the base-
line. Among the LVEDP-guided hydration group 7 patients
(7%) developed an increase in SCrP 25% of the baseline as
shown in (Fig. 1)
5.3. Secondary endpoint data analysis
We found no statistically signiﬁcant difference between the two
types of hydration regarding the short term occurrence of the
secondary endpoints within 30 days. In the standard hydration
group 2 patients died (2%) and 3 patients (3%) developedTable 1 Comparison between the two groups of hydration accordi
Standard (n= 16)
No. %
Death 2 2.0
Dialysis 0 0.0
Myocardial infarction 3 30
v2: value for Chi square; FE: Fisher Exact test.
Table 2 Comparison between LVEDP prior to contrast administra
guided hydration group.
Prior to contrast End o
No. % No.
LVEDP
<13 41 41.0 32
13–18 19 19.0 16
>18 40 40.0 52
Min.–Max. 0.0–44.0 0.0–43
Mean ± SD. 17.20 ± 9.62 19.21 ±
Median 18.0 19.0
% Of change 11.69
p: p value for comparing between prior to contrast and end of procedure
v2: McNemar test.
t: Paired t-test.
* Statistically signiﬁcant at p 6 0.05.myocardial infarction (MI). Among the LVEDP-guided
hydration group 1 patient died (1%) and no patients developed
MI. None of the patients in both groups required hemodialysis
as shown in (Table 1).
5.4. Analysis of the correlation between noninvasive LVFP
estimation and invasive LVEDP measurement
Analysis of the LVEDP measured invasively in the LVEDP-
guided hydration group revealed that 41 patients (41%) had
LVEDP <13 mmHg, 19 patients (19%) had LVEDP= 13–ng to the occurrence of the secondary endpoints.
LVEDP guided (n= 7) v2 FEp
No. %
1 1.0 0.338 1.000
0 0.0 – –
0 0.0 3.046 0.246
tion and at the end of the procedure (n= 100) in the LVEDP-
f procedure Test of sig. p
%
32.0 v2 = 18.000* <0.001*
16.0
52.0
.0 t= 5.952* <0.001*
9.09
.
Table 3 Relation between LVFP (E/e`) with LVEDP prior to contrast administration and at the end of the procedure.
E/e` v2 p j
<8 (n= 31) 8 – < 15 (n= 41) >15
No. % No. % No. %
Prior to contrast
<13 27 87.1 14 35.0 0 0.0 61.776* <0.001* 0.501
13–18 1 3.2 14 35.0 4 13.8
>18 3 9.7 12 30.0 25 86.2
End of procedure
<13 22 71.0 10 25.0 0 0.0 45.440* <0.001* 0.402
13–18 4 12.9 10 25.0 2 6.9
>18 5 16.1 20 50.0 27 93.1
v2: Chi square test.
j: kappa test
* Statistically signiﬁcant at p 6 0.05.
Table 4 Correlation between LVFP (E/e`) with LVEDP prior
to contrast administration and at the end of the procedure.
E/e`
r p
Prior to contrast 0.707* <0.001
End of procedure 0.623* <0.001
r: Pearson coefﬁcient.
* Statistically signiﬁcant at p 6 0.05.
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prior to contrast administration.
At the end of the procedure, 32 patients (32%) had
LVEDP<13 mmHg, 16 patients (16%) had LVEDP= 13–
18 mmHg and 52 patients (52%) had LVEDP >18 mmHg.
Statistically signiﬁcant correlation was found between
LVEDP prior to contrast administration and that at the end
of the procedure (p< 0.001). We found no signiﬁcant change
(11.69%) between the LVEDP measured prior to contrast
administration and that measured at the end of the procedure.
No changes of the rate of hydration in our patients were done
as shown in (Table 2).
Statistically signiﬁcant positive correlation was found
between the LVFP and the LVEDP both prior to contrast
administration and at the end of the procedure (p< 0.001).
Statistical signiﬁcant agreement between the LVFP measured
noninvasively and the LVEDP measured invasively was found.
However this correlation is shown mainly in the patients with
normal LVFP (E/e` < 8) and those with elevated LVFP
(E/e` > 15). This was not the case in the group with LVFP
(E/e` = 8–15) in which the LVFP was shown to be inconclusive
for the LVEDP as shown in (Tables 3 and 4).6. Conclusions
1. LVEDP-guided hydration is superior to standard hydration
in prevention of CIN during cardiac catheterization.
2. Hydration can be done based on LVFP in patients with
pre-procedure normal LVFP (E/e` < 8) and in patients with
pre-procedure elevated LVFP (E/e` > 15) but not in those
patients with inconclusive LVFP (E/e` = 8–15) in which
hydration should be guided by the invasively measured
LVEDP.
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